At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder (HAND)
In Brief
A Phase 2 clinical trial evaluating Fluconazole, Paroxetine, and 2 other interventions for HIV Associated Neurocognitive Disorder. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The purpose of this study is to see if paroxetine and fluconazole are safe and effective as a treatment for problems with memory, concentration, thinking, and judgment in people who are infected with HIV. Paroxetine is an antidepressant approved by the FDA to treat major depression. Fluconazole is an antifungal medication approved by the FDA to treat fungal infections.
Study Details
Timeline
Interventions
One 100 MG capsule taken twice daily, 12 hour dosing
Two 10 MG capsules paroxetine once daily in the evening
One capsule 100 MG fluconazole every 12 hours orally per day; Two 10 MG capsules paroxetine orally once daily in the evening
One capsule in the morning, three capsules in the evening